Retatrutide in New York (2026)
retatrutide · GLP-1 weight management · New York
About Retatrutide
Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.
See the full Retatrutide review for dosing, efficacy data, side effects, and the full pharmacy + telehealth program comparison.
Insurance coverage for Retatrutide in New York
NY Medicaid (NYRx) excludes drugs used for weight loss under 18 NYCRR §505.3(g)(3). GLP-1s are covered only for Medicaid-covered indications such as type 2 diabetes.
We do not track carrier-level coverage for Retatrutide. Check your plan's formulary or our insurance hub.
Telehealth and prescribing in New York
A telehealth clinician must be licensed in New York to prescribe Retatrutide to you while you are in New York.
Platforms differ in which drugs they prescribe, insurance handling, and clinical model. See our platform comparisons.
Compounded retatrutide
On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.
Retatrutide in New York: common questions
Is Retatrutide legal in New York?+
Yes. Retatrutide (retatrutide) is FDA-approved and legal in all 50 US states including New York. State-level differences appear in Medicaid coverage and clinician licensing, not in the legality of the medication itself.
Can I get Retatrutide via telehealth in New York?+
Yes, from a clinician licensed in New York. A telehealth clinician must be licensed in New York to prescribe Retatrutide to you while you are in New York.
Does New York Medicaid cover Retatrutide?+
Not covered for weight loss. NY Medicaid (NYRx) excludes drugs used for weight loss under 18 NYCRR §505.3(g)(3). GLP-1s are covered only for Medicaid-covered indications such as type 2 diabetes.
What's the cheapest way to get Retatrutide in New York?+
The main paths are insurance with prior authorization if your plan covers it, manufacturer cash-pay programs, or telehealth programs that include the medication. NovoCare Pharmacy sells Wegovy pens to cash-pay patients for $349 a month ($199 a month for the first two months for new patients through December 31, 2026). LillyDirect sells Zepbound vials for $299 (2.5 mg), $399 (5 mg), and $449 (7.5 to 15 mg) a month when refilled on time.
Is compounded Retatrutide still available in New York?+
Compounding rules are federal, not set by New York. On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.